Skip to main content

Table 2 Intervention characteristics of trials for each evaluation endpoint in the network meta-analysis

From: Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis

Treatment Overall survival Relapse
Trials aEvents/Patients % Trials bEvents/Patients %
CCRT 1 237/317 74.8 1 43/317 13.6
RS 7 338/468 72.2 6 175/493 35.5
CCRT+RS 3 156/191 81.7 2 37/108 34.3
NACT+RS 8 512/730 70.1 6 106/593 17.9
RT + RS 4 173/227 76.2 3 41/173 23.7
RT 4 276/409 67.5 3 68/266 25.6
Total   1692/2342 72.2   470/1950 24.1
  1. Abbreviations: CCRT concomitant chemotherapy and radiotherapy, RS Radical Surgery, NACT neoadjuvant chemotherapy, RT radiotherapy. aPeople who were alive during follow-up. bPatients with local or distant metastasis